This spike in GH then stimulates the liver to produce Insulin-like Growth Factor 1 (IGF-1)the key anabolic mediator responsible for many of Tesamorelins body composition and recovery benefits
In September 2025, the FDA issued more than 50 warning letters to companies compounding or marketing GLP-1 products including semaglutide, tirzepatide, and retatrutide
Your healthcare provider is the best person to determine if youre a suitable candidate for these medications and which one would be most effective for you, Dr
The bottom line As promising as Wegovy and other GLP-1 agonists may be, they are medications
A tumor-derived lactate/ENO1 lactylation feedback loop facilitates osimertinib resistance of lung adenocarcinoma
Many patients find that semaglutide's appetite suppression makes alcohol less appealing anyway, as they no longer feel driven to consume empty calories